Dayanand Medical College & Hospital | DMCH Neurology Department

Research site
Tagore nagar, Civil lines, Ludhiana, Punjab, India
Site insights

Top conditions

Non-alcoholic Fatty Liver Disease (3 trials)

Diabetes Mellitus (3 trials)

Fatty Liver (3 trials)

Brain Ischemia (2 trials)

Chronic Hepatitis C (2 trials)

Top treatments


Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


9 of 27
Status: Active
Trial type: Interventional
Funder type: Industry

A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes (SOUL)

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Participants...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Heart Failure
Drug: Placebo
Drug: Ziltivekimab

Researchers are looking for a better way to treat men who have non-metastatic castration-resistant prostate cancer (nmCRPC). This is a type of cancer...

Non-metastatic Castration-resistant Prostate Cancer
Drug: Darolutamide (Nubeqa, BAY1841788)

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivek...

Begins enrollment in 2 months
Acute Myocardial Infarction (AMI)
Cardiovascular Risk
Drug: Placebo
Drug: Ziltivekimab

This Phase 3, 2-arm, randomized, active comparator-controlled, open-label, multicenter study will compare the efficacy and health-related quality of...

Active, not recruiting
Multiple Myeloma
Drug: Selinexor
Drug: Dexamethasone

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy...

Active, not recruiting
Ulcerative Colitis
Drug: Filgotinib
Drug: Placebo

This study is being done to see if a combination of 2 medicines (called NNC0194-0499 and semaglutide) can reduce liver damage in patients with non al...

Active, not recruiting
Non-alcoholic Steatohepatitis
Drug: NNC0174 0833 10 mg/mL
Drug: NNC0194 0499 50 mg/mL

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabe...

Non-alcoholic Steatohepatitis
Drug: Placebo
Drug: Semaglutide

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Chronic Kidney Disease
Drug: Ziltivekimab C
Drug: Placebo (Ziltivekimab B)

Trial sponsors

Novo Nordisk logo

Novo Nordisk (8 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems